Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Revue Neurologique|May 10, 2016
Alpha-synuclein-based models of Parkinson's diseaseB Dehay, P-O FernagutExperimental Neurology|December 31, 2003
MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degenerationP O Fernagut, E Diguet, B Bioulac, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|October 27, 2004
Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in miceE Diguet, P-O Fernagut, C Scherfler, et al.Revue Neurologique|December 21, 2005
[Animal models of parkinsonism]I Ghorayeb, E Bezard, P O Fernagut, et al.Neuroscience|November 8, 2002
A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysisI Ghorayeb, P O Fernagut, L Hervier, et al.Neuroscience|March 6, 2003
Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout miceP-O Fernagut, S Chalon, E Diguet, et al.Neuroscience Letters|November 30, 2002
Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeysI Ghorayeb, P O Fernagut, N Stefanova, et al.Experimental Neurology|February 13, 2001
Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degenerationI Ghorayeb, Z Puschban, P O Fernagut, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degenerationI Ghorayeb, P O Fernagut, I Aubert, et al.Pageof 2